Effect of Madecassoside on Activation of Synovial Fibroblasts from Rats with Adjuvant Arthritis

ZHANG Li; SUN Sheng-lu; FAN Hai-bo; YANG Yuan-yuan; NING Qing

doi:10.13422/j.cnki.syfix.2014080173

您当前的位置：

首页 >

文章列表页 >

Effect of Madecassoside on Activation of Synovial Fibroblasts from Rats with Adjuvant Arthritis

更新时间：2024-01-04

- Effect of Madecassoside on Activation of Synovial Fibroblasts from Rats with Adjuvant Arthritis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 8, Pages: 173-177(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfix.2014080173
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
ZHANG Li, SUN Sheng-lu, FAN Hai-bo, et al. Effect of Madecassoside on Activation of Synovial Fibroblasts from Rats with Adjuvant Arthritis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 173-177.
DOI：

ZHANG Li, SUN Sheng-lu, FAN Hai-bo, et al. Effect of Madecassoside on Activation of Synovial Fibroblasts from Rats with Adjuvant Arthritis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 173-177. DOI： 10.13422/j.cnki.syfix.2014080173.

摘要

目的：研究羟基积雪草苷对佐剂关节炎大鼠滑膜成纤维细胞活化的影响。方法：将完全弗氏佐剂于大鼠右后足趾皮内注射0.1 mL致炎，建立佐剂关节炎大鼠模型，造模30 d后脱臼处死，取出关节处的滑膜，培养原代大鼠滑膜成纤维细胞（FLS），第3~6代细胞用于体外细胞实验。将对数生长期FLS以105个/mL接种于96孔板，利用白介素1β（IL-1β）诱导白介素-6（IL-6）的表达，羟基积雪草苷（终浓度1，5，10，20 μmol·L-1）和IL-1β（终浓度10 μg·L-1）作用24 h后收集上清。酶联免疫吸附试验（ELISA）检测上清中炎症因子IL-6的水平；实时定量PCR（Real time PCR）检测IL-6 mRNA的表达；蛋白印记法检细胞丝裂原激活的蛋白激酶（MAPK）、蛋白激酶C（PKC）、反应元件结合蛋白（CREB）的表达。结果：与正常组比较，模型组（IL-1β组）IL-6水平和IL-6 mRNA的表达明显升高。羟基积雪草苷预孵24 h后，浓度依赖性抑制IL-6的分泌并下调IL-6 mRNA的表达。模型组中细胞外信号调节激酶（ERK）、p38及PKC的磷酸化水平显著提高，羟基积雪草苷逆转了IL-1β诱导的ERK、p38及PKC的磷酸化；同时抑制IL-1β引起的CREB磷酸化。结论：羟基积雪草苷抑制佐剂关节炎大鼠滑膜成纤维细胞活化，其机制可能与抑制MAPK和PKC通路活化，降低CREB的磷酸化有关。

Abstract

Objective: To investigate the effect of madecassoside on interleukin-6(IL-6) production from synovial fibroblasts (FLS). Method: The rat adjuvant arthritis model was established by cultivating the original generation of FLS in rats. Interleukin-1 beta (IL-1β) was used to induce the expression of Interleukin-6 (IL-6) in FLS. Enzyme-linked immunosorbent assay (ELISA) method was used to detect FLS inflammatory factor levels of IL-6.Real time PCR method was used for detection of IL-6 and IL-1 mRNA expression. Western bloting method was used for mitogen-activated protein kinase (MAPK) pathways

protein kinase C (PKC) protein

and cAMP response element binding protein (CREB) protein expression. Result: Our results showed that IL-1β (10 μg·L-1) significantly increased the production of IL-6

and mRNA of IL-6

the activation of MAPK

PKC

and CREB which was relative to the synthesis of IL-6.Madecassoside (1

20 μmol·L-1) concentration-dependently decreased the production of IL-6 from FLS due to IL-1β. Conclusion: The mechanisms probably involve the inhibition of MAPK activation

PKC phosphorylation.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Inhibition Effects of Qingzhi Capsule on Inflammatory Reaction Attacked by LPS

Effect of Epigaloctechin-3-gallit (EGCG) on the Release of Inflammatory Cytokines and Expression of Neurotrophic Factors in Spinal Cord-injuried Rats

Studies on Anti-inflammatory Effects and Mechanism of

Influence of Sini Powder on IL-6 and IL-13 in Experimental Ulcerative Colitis Rats

Related Author

WENG Xiao-gang

Yang Qing

NIE Shu-qin

ZHAO Gui-zhi

LI Ru-bing

ZHOU Dan

XU Jiang-ping

YANG Ying-bao

Related Institution

The Department of Cardiovascular Diseases,the Affiliated Hospital of Guilin Medical College

Department of Pharmacology,School of Pharmaceutical Sciences,Southern Medical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰